ZA200203172B - Lactobacillus helveticus producing antihypertensive di- and tripeptides. - Google Patents

Lactobacillus helveticus producing antihypertensive di- and tripeptides.

Info

Publication number
ZA200203172B
ZA200203172B ZA200203172A ZA200203172A ZA200203172B ZA 200203172 B ZA200203172 B ZA 200203172B ZA 200203172 A ZA200203172 A ZA 200203172A ZA 200203172 A ZA200203172 A ZA 200203172A ZA 200203172 B ZA200203172 B ZA 200203172B
Authority
ZA
South Africa
Prior art keywords
tripeptides
lactobacillus helveticus
producing antihypertensive
antihypertensive
producing
Prior art date
Application number
ZA200203172A
Other languages
English (en)
Inventor
Annika Maeyrae-Maekinen
Tarja Suomalainen
Original Assignee
Valio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valio Ltd filed Critical Valio Ltd
Publication of ZA200203172B publication Critical patent/ZA200203172B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1427—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by dialysis, reverse osmosis or hyperfiltration, e.g. for concentrating or desalting
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/147—Helveticus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Water Supply & Treatment (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ZA200203172A 1999-11-01 2002-04-22 Lactobacillus helveticus producing antihypertensive di- and tripeptides. ZA200203172B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI992360A FI113741B (fi) 1999-11-01 1999-11-01 Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi

Publications (1)

Publication Number Publication Date
ZA200203172B true ZA200203172B (en) 2003-09-23

Family

ID=8555541

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200203172A ZA200203172B (en) 1999-11-01 2002-04-22 Lactobacillus helveticus producing antihypertensive di- and tripeptides.
ZA200203179A ZA200203179B (en) 1999-11-01 2002-04-22 Process for producing a product containing antihypertensive tripeptides.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200203179A ZA200203179B (en) 1999-11-01 2002-04-22 Process for producing a product containing antihypertensive tripeptides.

Country Status (23)

Country Link
US (2) US6890529B1 (cs)
EP (2) EP1226230B1 (cs)
JP (2) JP4172681B2 (cs)
KR (2) KR100704441B1 (cs)
CN (2) CN1164761C (cs)
AT (2) ATE285470T1 (cs)
AU (2) AU777795B2 (cs)
CA (2) CA2388354A1 (cs)
CZ (2) CZ294146B6 (cs)
DE (2) DE60010742T2 (cs)
DK (2) DK1226230T3 (cs)
EE (2) EE05461B1 (cs)
ES (2) ES2220557T3 (cs)
FI (1) FI113741B (cs)
HR (2) HRP20020378B1 (cs)
HU (2) HUP0203185A3 (cs)
NO (2) NO20022062L (cs)
NZ (2) NZ518470A (cs)
PL (2) PL364790A1 (cs)
PT (2) PT1226267E (cs)
RU (2) RU2270855C2 (cs)
WO (2) WO2001032836A1 (cs)
ZA (2) ZA200203172B (cs)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
FI112031B (fi) 2002-02-25 2003-10-31 Valio Oy Biologisesti aktiivisen tuotteen uusi käyttö
AU2003236689A1 (en) 2002-06-04 2003-12-19 Dsm Ip Assets B.V. Protein hydrolysate rich in tripeptides
EP1529114A1 (en) * 2002-08-09 2005-05-11 Chr. Hansen A/S Process for preparing peptides with anti-hypertensive properties
CA2509627A1 (en) * 2003-01-06 2004-07-22 Unilever Plc Fermented milk product comprising tripeptide vpp and/or ipp
TWI328457B (en) * 2003-03-18 2010-08-11 Suntory Holdings Ltd Angiotensin-converting enzyme inhibitory peptides
US7718171B2 (en) 2003-04-07 2010-05-18 Chr. Hansen A/S Reducing heart rate in mammals using milk derived fermentation products produced using Lactobacillus helveticus
BRPI0409536A (pt) 2003-05-05 2006-04-18 Unilever Nv processo para a preparação de um produto de caseìna hidrolisada, produtos de caseìna hidrolisada e produtos alimentìcios
EP1727440A1 (en) * 2004-03-19 2006-12-06 Campina Nederland Holding B.V. Method of preparing a food ingredient and food product having angiotensin-i-converting enzyme inhibiting properties and products thus obtained
CN101039685B (zh) 2004-03-31 2010-06-16 卡尔皮斯株式会社 预防、抑制肝病的制剂和预防、抑制肝病的功能食品
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
JP4723501B2 (ja) * 2004-07-05 2011-07-13 カルピス株式会社 ペプチド混合物の製造法、抗高血圧ペプチド含有発酵乳の製造法及び抗高血圧ペプチド製剤の製造法
EA011865B1 (ru) * 2004-07-12 2009-06-30 ДСМ Ай Пи ЭССЕТС Б.В. Протеиновые гидролизаты, снижающие давление крови
EP1685764A1 (en) 2005-01-27 2006-08-02 Globus Egg Sciences B.V. Anti-hypertensive functional food products
BRPI0514903A (pt) 2004-09-03 2008-06-24 Hansens Lab proteìnas vegetais ou leite fermentado compreendendo ligando de receptor e uso dos mesmos
FR2876876B1 (fr) * 2004-10-22 2007-02-16 Gervais Danone Sa Protection d'ingredients alimentaires bioactifs par l'utilisation de microorganismes presentant une capacite de metabolisation reduite
FR2876874B1 (fr) * 2004-10-22 2007-02-16 Gervais Danone Sa Protection d'ingredients alimentaires bioactifs par l'utilisation d'ingredients leurres
DK1827477T3 (en) * 2004-12-22 2015-11-09 Dsm Ip Assets Bv Antihypertensive Oligopeptides IN A SINGLE STEP ENZYMATIC
WO2006084560A1 (en) * 2005-02-09 2006-08-17 Unilever N.V. Composition comprising peptide
US8088597B2 (en) * 2005-02-24 2012-01-03 Dsm Ip Assets B.V. Blood pressure lowering peptides from glycomacropeptide
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
EP2439266B1 (en) * 2005-11-28 2017-02-01 DSM IP Assets B.V. Enzyme preparations yielding a clean taste
KR20080095898A (ko) 2006-02-14 2008-10-29 칼피스가부시키가이샤 혈관확장제
TWI418359B (zh) 2006-02-14 2013-12-11 Calpis Co Ltd 動脈硬化預防劑，血管內膜增厚抑制劑，血管內皮功能改善劑及功能性食品
DE602006004956D1 (de) * 2006-02-20 2009-03-12 Gervais Danone Sa Neue Stämme von Lactobacillus helveticus
EP1820850B1 (fr) * 2006-02-20 2009-02-25 Compagnie Gervais Danone Nouvelles souches de lactobacillus helveticus
EP1820851B9 (fr) * 2006-02-20 2012-06-27 Compagnie Gervais Danone Souches de Lactobacillus helveticus ne fermentant pas le lactose
CN100370019C (zh) * 2006-04-21 2008-02-20 江南大学 一种具有抗高血压作用的植物乳杆菌cw006
RU2457852C2 (ru) * 2006-05-15 2012-08-10 Валио Лтд Новое применение терапевтически эффективных пептидов
US20090111758A1 (en) * 2006-05-15 2009-04-30 Valio Ltd. Use of therapeutically useful peptides
NZ597178A (en) * 2006-09-04 2012-08-31 Megmilk Snow Brand Co Ltd Agent comprising Lactobacillus helveticus for accelerating the increase in and/or preventing the decrease in blood adiponectin level, and visceral fat accumulation inhibitor
PT1915913E (pt) * 2006-10-23 2016-02-16 Nestec Sa Modulação do sabor e do aroma de produtos lácteos por biotransformação
EP1952703B1 (de) * 2007-02-02 2010-08-25 May, Amadeus Alexander Produkt mit lebenden probiotischen Mikroorganismen
US10842813B2 (en) 2007-02-26 2020-11-24 Heartbeet Ltd Compositions of nitrates and methods of use thereof
US11759477B2 (en) 2007-02-26 2023-09-19 Heartbeet Ltd. Compositions of nitrates and methods of use thereof
MX2009010428A (es) * 2007-03-27 2009-12-01 Calpis Co Ltd Agente profilactico para insuficiencia renal.
BRPI0915107A2 (pt) * 2008-06-12 2015-08-11 Nestec Sa Cepas de lactobacillus heveticus para produção de peptídeos hipotensivos
DE102008032828A1 (de) 2008-07-02 2010-01-07 Technische Universität Dresden Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel
FI122531B (fi) * 2009-09-30 2012-03-15 Valio Oy Juusto ja menetelmä sen valmistamiseksi
CN102786579B (zh) * 2012-07-17 2014-07-09 上海交通大学 抗高血压活性肽vip
CN102786580A (zh) * 2012-07-17 2012-11-21 上海交通大学 抗高血压活性肽ivp
RU2580052C1 (ru) * 2014-12-24 2016-04-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" Штамм lactobacillus helveticus вкпм в-11176, полученный на доступных питательных средах
RU2577112C1 (ru) * 2014-12-25 2016-03-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" Штамм lactobacillus helveticus вкпм в-11175, полученный на доступных питательных средах
BR112019010024B1 (pt) 2016-12-02 2023-01-31 Fairlife, Llc Processos para a preparação de uma composição láctea seca, composição láctea seca, processo de reconstituição de um produto de leite e produto de leite reconstituído
RU2685912C1 (ru) * 2018-03-14 2019-04-23 Федеральное государственное автономное научное учреждение "Научно-исследовательский институт хлебопекарной промышленности" Штамм бактерий lactobacillus amylolyticus, используемый для приготовления термофильной заквашенной заварки
RU2728171C2 (ru) * 2018-11-08 2020-07-28 Общество с ограниченной ответственностью "Инновационные биотехнологии" (ООО "Инбиотех") Штамм бактерий Lactobacillus helveticus T-5068, используемый в качестве закваски прямого внесения для приготовления кисломолочных продуктов
CN109517763B (zh) * 2018-12-27 2022-03-22 内蒙古农业大学 瑞士乳杆菌h11及其应用
TWI713972B (zh) * 2019-01-14 2020-12-21 大江生醫股份有限公司 改善呼吸道健康之益生菌株及其組合物與用途
WO2021195718A1 (en) * 2020-04-02 2021-10-07 Ahtesh Fatah Bashir Milk fermentation process
CN112029784A (zh) * 2020-09-16 2020-12-04 内蒙古农业大学 一个与蛋白水解能力相关的基因及基于该基因的高蛋白水解能力瑞士乳杆菌的筛选方法
KR102684805B1 (ko) 2023-12-20 2024-07-12 푸른하늘환경주식회사 우수 유출수의 정화 처리 장치
KR102687298B1 (ko) 2023-12-20 2024-07-22 푸른하늘환경주식회사 비점오염물질 저감 및 우수 정화 장치
CN117986337B (zh) * 2024-02-02 2024-08-16 杭州御寿生物科技有限公司 一种提高免疫力的益生菌组合物以及在治疗疾病中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483748A1 (fr) * 1980-06-06 1981-12-11 Corning Glass Works Procede d'hydrolyse du lactose contenu dans les lactoserums a l'aide de lactase immobilisee
SU1264889A1 (ru) * 1984-07-25 1986-10-23 Киевский Ордена Трудового Красного Знамени Технологический Институт Пищевой Промышленности Способ производства молочно-белкового продукта дл плавлени
JPS6153216A (ja) * 1984-08-23 1986-03-17 Rikagaku Kenkyusho 高血圧症予防治療剤
JP2782142B2 (ja) * 1992-07-23 1998-07-30 カルピス株式会社 アンジオテンシン変換酵素阻害剤及びその製造法
JP2782153B2 (ja) 1992-11-09 1998-07-30 カルピス株式会社 アンジオテンシン変換酵素阻害ペプチドの製造法
JP2824821B2 (ja) 1993-11-04 1998-11-18 カルピス株式会社 乳酸菌及び発酵乳製品
GB2294191B (en) * 1994-10-06 1997-10-01 Waterford Creamery Ltd Cheese manufacture
JP3782837B2 (ja) * 1995-04-10 2006-06-07 カルピス株式会社 血圧降下剤及びその製造法
JPH09188694A (ja) 1996-01-10 1997-07-22 Otsuka Shokuhin Kk ペプチド、アンジオテンシン変換酵素阻害組成物及びその製法
JP3746556B2 (ja) 1996-02-09 2006-02-15 カルピス株式会社 プラスミド及びプラスミドベクター
US5854029A (en) * 1996-08-02 1998-12-29 Calpis Co., Ltd. Method for preparing antihypertensive agent
JP3028411B2 (ja) * 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌
JP4727770B2 (ja) * 1997-09-26 2011-07-20 カルピス株式会社 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
GB9720633D0 (en) * 1997-09-29 1997-11-26 Univ Bristol BHV-2 vector
FI104783B (fi) 1998-02-12 2000-04-14 Valio Oy Herasuolajauhe, menetelmä sen valmistamiseksi ja sen käyttö
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
US6514941B1 (en) * 1999-12-10 2003-02-04 Campina Melkunie B.V. Method of preparing a casein hydrolysate enriched in anti-hypertensive peptides

Also Published As

Publication number Publication date
JP4172681B2 (ja) 2008-10-29
ES2220557T3 (es) 2004-12-16
EE200200230A (et) 2003-06-16
AU1149901A (en) 2001-05-14
FI19992360L (fi) 2001-05-02
WO2001032836A1 (en) 2001-05-10
HU226200B1 (en) 2008-06-30
EP1226230B1 (en) 2004-12-22
ZA200203179B (en) 2003-07-22
NO330951B1 (no) 2011-08-22
NZ518493A (en) 2003-03-28
RU2270855C2 (ru) 2006-02-27
KR100718709B1 (ko) 2007-05-16
ATE266735T1 (de) 2004-05-15
NO20022062D0 (no) 2002-04-30
DE60016959D1 (de) 2005-01-27
EP1226267A1 (en) 2002-07-31
CZ302271B6 (cs) 2011-01-19
CA2387738C (en) 2008-09-16
HRP20020378A2 (en) 2003-08-31
PL355670A1 (pl) 2004-05-04
CZ294146B6 (cs) 2004-10-13
US6890529B1 (en) 2005-05-10
DK1226267T3 (da) 2004-09-20
CA2387738A1 (en) 2001-05-10
AU777795B2 (en) 2004-10-28
HUP0203256A2 (hu) 2003-01-28
AU1149801A (en) 2001-05-14
CN1197956C (zh) 2005-04-20
PL364790A1 (pl) 2004-12-13
WO2001032905A1 (en) 2001-05-10
EP1226230A1 (en) 2002-07-31
FI113741B (fi) 2004-06-15
DK1226230T3 (da) 2005-04-04
JP2003513621A (ja) 2003-04-15
RU2276689C2 (ru) 2006-05-20
HRP20020378B1 (en) 2005-06-30
US6972282B1 (en) 2005-12-06
HUP0203185A2 (hu) 2003-01-28
JP3695648B2 (ja) 2005-09-14
PT1226267E (pt) 2004-08-31
AU769432B2 (en) 2004-01-29
EE200200231A (xx) 2003-06-16
CA2388354A1 (en) 2001-05-10
KR100704441B1 (ko) 2007-04-24
EP1226267B1 (en) 2004-05-12
CZ20021431A3 (cs) 2002-08-14
ES2234686T3 (es) 2005-07-01
EE05461B1 (et) 2011-08-15
NZ518470A (en) 2003-03-28
DE60010742D1 (de) 2004-06-17
KR20020060220A (ko) 2002-07-16
PT1226230E (pt) 2005-04-29
CN1387577A (zh) 2002-12-25
KR20020064895A (ko) 2002-08-10
DE60010742T2 (de) 2005-05-12
HUP0203256A3 (en) 2005-11-28
CN1164761C (zh) 2004-09-01
DE60016959T2 (de) 2005-12-22
NO20022061L (no) 2002-06-28
CN1387564A (zh) 2002-12-25
PL204119B1 (pl) 2009-12-31
HUP0203185A3 (en) 2005-07-28
HRP20020377A2 (en) 2003-08-31
JP2003513636A (ja) 2003-04-15
ATE285470T1 (de) 2005-01-15
NO20022061D0 (no) 2002-04-30
HRP20020377B1 (en) 2005-06-30
NO20022062L (no) 2002-06-28
CZ20021369A3 (cs) 2002-07-17

Similar Documents

Publication Publication Date Title
ZA200203172B (en) Lactobacillus helveticus producing antihypertensive di- and tripeptides.
Hafeez et al. Strategies of producing bioactive peptides from milk proteins to functionalize fermented milk products
Leclerc et al. Antihypertensive activity of casein-enriched milk fermented by Lactobacillus helveticus
PL339343A1 (en) Lactic acid bacterium lactobacillus helveticus of high tripeptides productivity, fermented diary product and method of obtaining said product
IL151338A0 (en) Cultured protein hydrolysate
DE69831420D1 (de) Herstellung von nahrungsmitteln durch fermentierung von sojamilch mit streptococcus thermophilus
JP2005517424A5 (cs)
RU2004128448A (ru) Повышение биодоступности минеральных веществ посредством применения биологически активных пептидов
FI945453A0 (fi) Hiivatuotteiden valmistus laktoosia sisältävistä substraateista
TW200511935A (en) Composition with heart rate reducing properties
WO2001064899A3 (de) Nukleotidsequenzen kodierend für proteine beteiligt an der biosynthese von l-serin, verbessertes verfahren zur mikrobiellen herstellung von l-serin sowie ein dazu geeigneter genetisch veränderter mikroorganismus
ATE376361T1 (de) Fermentiertes, sojaproteine enthaltendes lebensmittel
Samurailatpam et al. Bioactive Peptides in Fermented Food Products: Production and Functionality
UA19600A (uk) Спосіб виробhицтва голубців
JP2000166510A (ja) 健康食品の製造方法
BG108541A (en) Bread products of higher biological values